» Articles » PMID: 9820504

Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells

Overview
Journal J Immunol
Date 1998 Nov 20
PMID 9820504
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Following an infection or immunization, a primary CD8+ T cell response generally rises then falls rapidly before giving rise to a "memory" response. When we immunized mice with recombinant viral immunogens optimized to enhance the lytic capability of CD8+ T cells, we measured a profound depression in Ag-specific effector function after early restimulation. Indeed, a "mirror image" cytolytic capability was observed: the most powerful immunogens, as measured by cytolytic capacity 6 days after immunization, elicited the weakest secondary immune response when evaluated following an additional 6 days after restimulation. To understand the mechanism of this suppression, we examined the fate of splenocytes immunized with a vaccinia virus encoding Ag and IL-2 then restimulated ex vivo. We found that these splenocytes underwent an apoptotic cell death, upon early restimulation, that was not dependent on the engagement of the FasR (CD95). Unlike previously described mechanisms of "propriocidal cell death" and "clonal exhaustion," the cell death we observed was not an inherent property of the CD8+ T cells but rather was due to a population of splenocytes that stained positive for both the Mac-1 and Gr-1 surface markers. Deletion of these cells in vitro or in vivo completely abrogated the observed suppression of cytolytic reactivity of Ag-specific CD8+ T cells. These observations could account for the apparent absence of Ag-specific immune responses after some current vaccination regimens employing powerful immunogens. Finally, our results may shed new light on a mechanism for the suppression of CD8+ T cell responses and its effect on vaccine efficacy and on immune memory.

Citing Articles

Chinese Medicines and Natural Medicine as Immunotherapeutic Agents for Gastric Cancer: Recent Advances.

Zhang Z, Chen Z, Que Z, Fang Z, Zhu H, Tian J Cancer Rep (Hoboken). 2024; 7(9):e2134.

PMID: 39233637 PMC: 11375283. DOI: 10.1002/cnr2.2134.


Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Wittling M, Knochelmann H, Wyatt M, Rangel Rivera G, Cole A, Lesinski G J Immunother Cancer. 2024; 12(6).

PMID: 38945552 PMC: 11216073. DOI: 10.1136/jitc-2023-008715.


Myeloid-derived suppressor cells in cancer and cancer therapy.

Lasser S, Ozbay Kurt F, Arkhypov I, Utikal J, Umansky V Nat Rev Clin Oncol. 2024; 21(2):147-164.

PMID: 38191922 DOI: 10.1038/s41571-023-00846-y.


Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more.

Shibata M, Nanno K, Yoshimori D, Nakajima T, Takada M, Yazawa T Oncotarget. 2022; 13:1273-1285.

PMID: 36395389 PMC: 9671473. DOI: 10.18632/oncotarget.28303.


An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).

Ben-Meir K, Twaik N, Meirow Y, Baniyash M Curr Protoc. 2022; 2(10):e558.

PMID: 36239438 PMC: 11648823. DOI: 10.1002/cpz1.558.


References
1.
Moskophidis D, Lechner F, Pircher H, Zinkernagel R . Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 1993; 362(6422):758-61. DOI: 10.1038/362758a0. View

2.
Razvi E, Welsh R . Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol. 1993; 67(10):5754-65. PMC: 237993. DOI: 10.1128/JVI.67.10.5754-5765.1993. View

3.
GAVIN M, Gilbert M, Riddell S, Greenberg P, Bevan M . Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol. 1993; 151(8):3971-80. View

4.
Schleifer K, Mansfield J . Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol. 1993; 151(10):5492-503. View

5.
Critchfield J, Racke M, Zuniga-Pflucker J, Cannella B, Raine C, Goverman J . T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 1994; 263(5150):1139-43. DOI: 10.1126/science.7509084. View